Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1968 Jun;3(5):447–455.

The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies

P G Frost, P J Lachmann
PMCID: PMC1578906  PMID: 5662583

Abstract

A group of sera from hospital patients and normal subjects has been tested for the presence of antinuclear antibodies, and the amount of labile inhibitor to desoxyribonuclease 1 present in each of the sera estimated. It has been found that the presence of antinuclear antibodies is associated with a high level of inhibitor to a statistically significant degree.

It has also been found that this inhibitor is formed during the clotting of whole blood and that it is derived from platelets. A possible relationship between the inhibitor, its formation during the clotting of blood, and the characteristic presence of antinuclear antibodies in systemic lupus erythematosus is discussed.

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FEINSTEIN R. N., GREEN F. O. An activator of deoxyribonuclease in rat plasma. Arch Biochem Biophys. 1956 Feb;60(2):502–504. doi: 10.1016/0003-9861(56)90458-1. [DOI] [PubMed] [Google Scholar]
  2. FEINSTEI R. N. Activation of the neutral deoxyribonuclease. J Biol Chem. 1960 Mar;235:733–737. [PubMed] [Google Scholar]
  3. GUPTA S., HERRIOTT R. M. Nucleases and their inhibitors in the cellular components of human blood. Arch Biochem Biophys. 1963 Apr;101:88–95. doi: 10.1016/0003-9861(63)90538-1. [DOI] [PubMed] [Google Scholar]
  4. HENSTELL H. H., FREEDMAN R. I. The viscosimetric determination of desoxyribonuclease inhibition. Cancer Res. 1952 May;12(5):341–345. [PubMed] [Google Scholar]
  5. HUMPHREY J. H., JAQUES R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J Physiol. 1955 Apr 28;128(1):9–27. doi: 10.1113/jphysiol.1955.sp005289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. JOHNSON A. J., GOGER P. R., TILLETT W. S. The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients. J Clin Invest. 1954 Dec;33(12):1670–1686. doi: 10.1172/JCI103048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KURNICK N. B., SCHWARTZ L. I., PARISER S., LEE S. L. A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes. J Clin Invest. 1953 Mar;32(3):193–201. doi: 10.1172/JCI102727. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES